tert-butyl 1-oxa-4,9-diazaspiro[5.5]undecane-4-carboxylate
95%
- Product Code: 75005
CAS:
1023595-11-0
| Molecular Weight: | 256.34 g./mol | Molecular Formula: | C₁₃H₂₄N₂O₃ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD11227066 | |
| Melting Point: | Boiling Point: | 365.039℃ at 760 mmHg | |
| Density: | 1.11g/ml | Storage Condition: | 2-8°C, away from light, dry |
Product Description:
This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of novel drug candidates. It serves as a key intermediate in the creation of complex molecules, often targeting neurological and psychiatric disorders. Its spirocyclic structure is valuable for designing compounds that interact with specific biological receptors, enhancing drug efficacy and selectivity. Additionally, it is employed in medicinal chemistry to optimize pharmacokinetic properties, such as bioavailability and metabolic stability, of potential therapeutic agents. Its role in the development of central nervous system (CNS) drugs highlights its importance in advancing treatments for conditions like depression, anxiety, and neurodegenerative diseases.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 1.000 | 10-20 days | $564.01 |
+
-
|
tert-butyl 1-oxa-4,9-diazaspiro[5.5]undecane-4-carboxylate
This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of novel drug candidates. It serves as a key intermediate in the creation of complex molecules, often targeting neurological and psychiatric disorders. Its spirocyclic structure is valuable for designing compounds that interact with specific biological receptors, enhancing drug efficacy and selectivity. Additionally, it is employed in medicinal chemistry to optimize pharmacokinetic properties, such as bioavailability and metabolic stability, of potential therapeutic agents. Its role in the development of central nervous system (CNS) drugs highlights its importance in advancing treatments for conditions like depression, anxiety, and neurodegenerative diseases.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :